In the latest trading session,, 0.52 million GoodRx Holdings Inc (NASDAQ:GDRX) shares changed hands as the company’s beta touched 1.31. With the company’s most recent per share price at $4.69 changed hands at -$0.01 or -0.28% at last look, the market valuation stands at $1.79B. GDRX’s current price is a discount, trading about -97.44% off its 52-week high of $9.26. The share price had its 52-week low at $4.63, which suggests the last value was 1.28% up since then. When we look at GoodRx Holdings Inc’s average trading volume, we note the 10-day average is 2.29 million shares, with the 3-month average coming to 1.27 million.
Analysts gave the GoodRx Holdings Inc (GDRX) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.95. If we narrow down to specifics, the data shows that 0 out of 16 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 7 recommended GDRX as a Hold, 9 felt it is a Buy and 0 rated the stock as Underweight. GoodRx Holdings Inc’s EPS for the current quarter is expected to be 0.1.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
GoodRx Holdings Inc (NASDAQ:GDRX) trade information
Instantly GDRX was in red as seen in intraday trades today. With action -23.29%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -30.05%, with the 5-day performance at -23.29% in the red. However, in the 30-day time frame, GoodRx Holdings Inc (NASDAQ:GDRX) is -32.66% down. Looking at the short shares, we see there were 8.69 million shares sold at short interest cover period of 10.07 days.
The consensus price target for the stock as assigned by Wall Street analysts is 10, meaning bulls need an upside of 53.1% from its recent market value. According to analyst projections, GDRX’s forecast low is 3 with 45 as the target high. To hit the forecast high, the stock’s price needs a -859.49% plunge from its current level, while the stock would need to tank 36.03% for it to hit the projected low.
GoodRx Holdings Inc (GDRX) estimates and forecasts
Data shows that the GoodRx Holdings Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -35.53% over the past 6 months, a 21.43% in annual growth rate that is considerably higher than the industry average of 7.10%. Year-over-year growth is forecast to reach 5.90% up from the last financial year.
Consensus estimates given by 14 financial analysts project the company’s revenue in the current quarter to hit an average of 201.17M. 10 analysts are of the opinion that GoodRx Holdings Inc’s revenue for the current quarter will be 203.98M. The company’s revenue for the corresponding quarters a year ago was 196.64M and 197.88M respectively. According to analysts, the company will likely register a growth in its current quarter sales, forecast at 2.30%. The estimates for the next quarter sales put growth at 3.10%.
The 2024 estimates are for GoodRx Holdings Inc earnings to increase by 22.78%, but the outlook for the next 5-year period is at 14.47% per year.
GDRX Dividends
GoodRx Holdings Inc is expected to release its next quarterly earnings report on 2025-Feb-26.
GoodRx Holdings Inc (NASDAQ:GDRX)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 11.77% of GoodRx Holdings Inc shares while 62.77% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 71.14%. There are 62.77% institutions holding the GoodRx Holdings Inc stock share, with FRANCISCO PARTNERS MANAGEMENT, LP the top institutional holder. As of 2024-06-30, the company held 17.9666% of the shares, roughly 70.08 million GDRX shares worth $546.61 million.
VANGUARD GROUP INC holds the second largest percentage of outstanding shares, with 2.0849% or 8.13 million shares worth $63.43 million as of 2024-06-30.
